GlassScriptPhysician profile
Scott Novy
NPI 1225869175
$946.46
in general payments reported to CMS, 2019-2025
7 companies · $946 in 2025
The $946 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867 · Education: $79.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.46 |
| Education | $79.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $538.59 | 2025 | |
| Jazz Pharmaceuticals INC. | $117.89 | 2025 | |
| Axsome Therapeutics, INC. | $113.41 | 2025 | Sunosi |
| Lilly USA, LLC | $87.79 | 2025 | Zepbound, Mounjaro |
| Avadel Cns Pharmaceuticals, LLC | $45.44 | 2025 | Lumryz |
| Fisher & Paykel Healthcare INC | $24.08 | 2025 | Fisher & Paykel Healthcare |
| Inspire Medical Systems, INC. | $19.26 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Novy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.